These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 28001091)

  • 41. [The treatment of adult glioma is multiphasic].
    Mäenpää HO
    Duodecim; 2010; 126(14):1669-75. PubMed ID: 20804085
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endovascular therapies for malignant gliomas: Challenges and the future.
    Su YS; Ali R; Feroze AH; Li G; Lawton MT; Choudhri O
    J Clin Neurosci; 2016 Apr; 26():26-32. PubMed ID: 26857294
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Treatment of recurrent malignant brain gliomas by surgical excision combined with biodegradable polymers of interstitial chemotherapy].
    Qi ST; Qiu BH
    Zhonghua Zhong Liu Za Zhi; 2004 Jan; 26(1):58-61. PubMed ID: 15059361
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HSV1716 injection into the brain adjacent to tumour following surgical resection of high-grade glioma: safety data and long-term survival.
    Harrow S; Papanastassiou V; Harland J; Mabbs R; Petty R; Fraser M; Hadley D; Patterson J; Brown SM; Rampling R
    Gene Ther; 2004 Nov; 11(22):1648-58. PubMed ID: 15334111
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multimodality treatment of malignant gliomas. Comparison of several adjuvant approaches.
    Jellinger K; Volc D; Grisold W; Podreka I; Böck F; Schuster H; Alth G; Kogelnik HD
    Zentralbl Neurochir; 1981; 42(2-3):99-119. PubMed ID: 6267846
    [No Abstract]   [Full Text] [Related]  

  • 46. Preliminary clinical report on safety and efficacy of photodynamic therapy using talaporfin sodium for malignant gliomas.
    Akimoto J; Haraoka J; Aizawa K
    Photodiagnosis Photodyn Ther; 2012 Jun; 9(2):91-9. PubMed ID: 22594978
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Advanced treatment in high-grade gliomas.
    Xiong L; Wang F; Qi Xie X
    J BUON; 2019; 24(2):424-430. PubMed ID: 31127986
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Recurrences of malignant astrocytomas (III-IV) and glioblastomas. Therapeutic approach (author's transl)].
    Constans JP; Schlienger M; Haie C
    Neurochirurgie; 1981; 27(5):321-4. PubMed ID: 7335136
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reoperation for recurrent malignant gliomas: what are your indications?
    Kelly PJ; Rappaport ZH; Bhagwati SN; Ushio Y; Vapalahti M; de Tribolet N
    Surg Neurol; 1997 Jan; 47(1):39-42. PubMed ID: 8986164
    [No Abstract]   [Full Text] [Related]  

  • 50. [Prognostic evaluations of recurrent gliomas and preliminary efficacies of combined modality therapy].
    Zhang X; Yao Y; Qin ZY; Wang Y; Wu JS; Mao Y; Zhou LF
    Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(1):11-4. PubMed ID: 23578445
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thymidine kinase activation of ganciclovir in recurrent malignant gliomas: a gene-marking and neuropathological study.
    Harsh GR; Deisboeck TS; Louis DN; Hilton J; Colvin M; Silver JS; Qureshi NH; Kracher J; Finkelstein D; Chiocca EA; Hochberg FH
    J Neurosurg; 2000 May; 92(5):804-11. PubMed ID: 10794295
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Standard of care and future pharmacological treatment options for malignant glioma: an urgent need for screening and identification of novel tumor-specific antigens.
    Batich KA; Sampson JH
    Expert Opin Pharmacother; 2014 Oct; 15(14):2047-61. PubMed ID: 25139628
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New therapeutic agents in the treatment of recurrent high-grade gliomas.
    Brandes AA; Pasetto LM
    Forum (Genova); 2000; 10(2):121-31. PubMed ID: 10875974
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma.
    Vredenburgh JJ; Desjardins A; Herndon JE; Dowell JM; Reardon DA; Quinn JA; Rich JN; Sathornsumetee S; Gururangan S; Wagner M; Bigner DD; Friedman AH; Friedman HS
    Clin Cancer Res; 2007 Feb; 13(4):1253-9. PubMed ID: 17317837
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecularly targeted therapies for recurrent glioblastoma: current and future targets.
    Lau D; Magill ST; Aghi MK
    Neurosurg Focus; 2014 Dec; 37(6):E15. PubMed ID: 25434384
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Therapeutic strategies for the management of gliomas].
    Hottinger AF; Stupp R
    Rev Neurol (Paris); 2008; 164(6-7):523-30. PubMed ID: 18565350
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High grade gliomas.
    Ganz JC
    Prog Brain Res; 2022; 268(1):259-270. PubMed ID: 35074084
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Update in the treatment of high-grade Gliomas.
    Lukas RV; Nicholas MK
    Neurol Clin; 2013 Aug; 31(3):847-67. PubMed ID: 23896509
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Valproic acid, compared to other antiepileptic drugs, is associated with improved overall and progression-free survival in glioblastoma but worse outcome in grade II/III gliomas treated with temozolomide.
    Redjal N; Reinshagen C; Le A; Walcott BP; McDonnell E; Dietrich J; Nahed BV
    J Neurooncol; 2016 May; 127(3):505-14. PubMed ID: 26830093
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A phase I dose-escalation study of fractionated stereotactic radiosurgery in combination with gefitinib in patients with recurrent malignant gliomas.
    Schwer AL; Damek DM; Kavanagh BD; Gaspar LE; Lillehei K; Stuhr K; Chen C
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):993-1001. PubMed ID: 17967517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.